Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-004530

Options or other derivatives

  • Director acquired 81,906 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hege Kristen Director 2024-01-15 Grant or award · Option to purchase Ordinary Shares +81,906 81,906 D
Loading xslF345X05/tm243270-11_4seq1.xml…